Acute coronary syndrome patients benefit from platelet glycoprotein IIb/IIIa inhibition as part of an initially medical treatment strategy: Results of a meta-analysis of phase III randomized trials.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Boersma, E; Harrington, RA; Van de Werf, FV; Armstrong, PW; Simes, J; Hasselblad, V; Simoons, ML

Published Date

  • October 23, 2001

Published In

Volume / Issue

  • 104 / 17

Start / End Page

  • 782 - 782

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0009-7322

Language

  • English